The company's products have shown remarkable success in veterinary applications, leading to profitable commercial activities. ReGum™ Vet and VetFoam™ have gained adoption among veterinarians worldwide, confirming the technology's safety, effectiveness and usability.
BioChange has secured funding through grants, investments, and strategic partnerships with elite academic and medical institutions like Stanford University and the University of Milan. Its accomplished team of experts that brings extensive experience in biotech entrepreneurship, biomedical engineering, and medical device innovation.
BioChange aims to repair damaged tissues and eventually grow functional organs, addressing various unmet needs and significantly improving human well-being.